May be able to pick up shares in the 9's or low 10's. Check out the chart and pays monthly dividend.
Have held it since it went IPO and loved the divy and cap gains - sold it and buying again here.
No, shares purchased (acquired) on ex-date are not eligible for the dividend, even if purchased during the pre-market. Shares sold however are eligible for the dividend.
So, no they shouldn't as their shares would not be acquired until tomorrow (the ex-date). They would have to hold for 30 days (next ex-div date) to be eligible for the subsequent dividend.
25 cent SPO haircut and 9 cent dividend haircut should price FSC at 9.80 or so at open and be an opportunity to buy at or below NAV and the SPO price.
It's not unlikely FSC could climb to 10.10 in 3 weeks and you can bank over 3 months of dividends with this action.
You can file as many or as few quarterlies as you need. You are not required to file one each quarter but should file at the end of the quarter when your unexpected taxable income appeared.
I've done this for consulting income and for capital gains.
Overweight as that is, it still may not be awful since BDCs are also diversified through their own investments. Now if you held just HTGC and other technology BDCs, I would worry more.
But yeah, 1/3 of anything in one sector is gonna make you walk like a duck. :)
Started a position in FSIC at 10.45 and intend to hold and accrue shares.
I'm not a big expert on financing costs Kel, but I did take this away as prudent business practice - FSIC got their credit rating raised to BBB the day vefore they announced the issuance of the 4% notes. That just seems to be smart and increases confidence that while I'm no expert, they at least executed this in a manner that made sense to this novice.
I have just 1k shares of RSO as it has just stalled for ages now. Did well with it as I bought and sold some 15k shares over 6 years and held a core then about 3k shares. Not doing DRIP on it either now. Am holding as my basis is low 5's and would buy more if it were around 5.20 or lower. It treated me well but obviously has underperformed for several years now.
FSIC, OAKS, NRZ, ARP are on my short-term buy list. Picked up some OAKS Monday morning at 11.20, have buy orders in for FSIC, NRZ, and ARP at 1-2% lower than they are currently trading. All seem good values in a market where it is hard to find any discounted equities.
I have tons of FSC so am reluctant to buy more but the current price in low 10's is a deal and I did pick more up as recent as 9.80 just last week. Am sitting on some 3.5k shares that is about 2.5% of my portfolio and that is plenty for any single equity.
I think FSIC is promising though I don't have any shares yet. I may get some after the x-dates if it should trade below 10.50. Regret not picking some up in the 9's when it was on my watch list.
Have just 1500 shares of RSO now and averaged at low 5's. That's about a quarter of my usual weight in RSO that I kept for years and I haven't traded in and out of RSO in several years.
Am not really worried about the dividend but am not optimistic for much price appreciation.
Earnings don't matter materially to equities like this. IT is all about progress toward reaching potential and that is measured by benchmark events such as approvals, successfully executing testing phases, results of studies, and the underwriting of research, development, production, and marketing by a large sponsor.
More important than earnings will be the conference presentations of new data next week and whether they draw attention from sponsors or interest in acquiring PPHM's product line.
As for earnings, I expect a loss. But PPHM has enough money in the bank to cover the costs of its latest sunrise testing and that is what matters. The burn rate on cash can't be too high, but then even if it is, the key thing will be the attention drawn to its products from the research it reports.
Or, short shares could be tinder when they cover from any news the company might release that is favrable for trials, bavi, earnings, cost of trials, partnering.... yeah, a lot of potential good news.
Keep in mind that book value increased 1 cent (albeit small) while having paid out the dividend in Q4. So the premium is not as much an issue as it might be given earnings were over 50% higher than expected.
Instead, consider that NYMT may have to announce an additional distribution because future-looking statements are very positive and last quarter's earnings are in the bank.